Spinal muscular atrophy: Recent advances and future prospects

被引:67
|
作者
Nicole, S [1 ]
Diaz, CC [1 ]
Frugier, T [1 ]
Melki, J [1 ]
机构
[1] Univ Evry, INSERM, Mol Neurogenet Lab, F-91057 Evry, France
关键词
mouse model; pathophysiology; SMA; SMN; therapeutics;
D O I
10.1002/mus.10110
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Spinal muscular atrophies (SMA) are characterized by degeneration of lower motor neurons associated with muscle paralysis and atrophy. Childhood SMA is a frequent recessive autosomal disorder and represents one of the most common genetic causes of death in childhood. Mutations of the SMN1 gene are responsible for SMA. The knowledge of the genetic basis of SMA, a better understanding of SMN function, and the recent generation of SMA mouse models represent major advances in the field of SMA. These are starting points towards understanding the pathophysiology of SMA and developing therapeutic strategies for this devastating neurodegenerative disease, for which no curative treatment is known so far. (C) 2002 Wiley Periodicals, Inc.
引用
收藏
页码:4 / 13
页数:10
相关论文
共 50 条
  • [11] Developments in the discovery of drugs for spinal muscular atrophy: successful beginnings and future prospects
    Pruss, Rebecca M.
    EXPERT OPINION ON DRUG DISCOVERY, 2011, 6 (08) : 827 - 837
  • [12] Prospects for the gene therapy of spinal muscular atrophy
    Passini, Marco A.
    Cheng, Seng H.
    TRENDS IN MOLECULAR MEDICINE, 2011, 17 (05) : 259 - 265
  • [13] Advances and limitations for the treatment of spinal muscular atrophy
    John W. Day
    Kelly Howell
    Amy Place
    Kimberly Long
    Jose Rossello
    Nathalie Kertesz
    George Nomikos
    BMC Pediatrics, 22
  • [14] Spinal Muscular Atrophy and Common Therapeutic Advances
    Qomi, Saeed Bozorg
    Asghari, Amir
    Salmaninejad, Arash
    Mojarrad, Majid
    FETAL AND PEDIATRIC PATHOLOGY, 2019, 38 (03) : 226 - 238
  • [15] Advances and limitations for the treatment of spinal muscular atrophy
    Day, John W.
    Howell, Kelly
    Place, Amy
    Long, Kimberly
    Rossello, Jose
    Kertesz, Nathalie
    Nomikos, George
    BMC PEDIATRICS, 2022, 22 (01)
  • [16] Advances in modeling and treating spinal muscular atrophy
    Van Alstyne, Meaghan
    Pellizzoni, Livio
    CURRENT OPINION IN NEUROLOGY, 2016, 29 (05) : 549 - 556
  • [17] Advances in therapeutic development for spinal muscular atrophy
    Howell, Matthew D.
    Singh, Natalia N.
    Singh, Ravindra N.
    FUTURE MEDICINAL CHEMISTRY, 2014, 6 (09) : 1081 - 1099
  • [18] Recent therapeutic developments in spinal muscular atrophy
    Bora, Gamze
    Yesbek Kaymaz, Ayse
    Bekircan Kurt, Can Ebru
    Haliloglu, Vildan Goknur
    Topaloglu, Haluk Aydin
    Erdem Yurter, Hayat
    Erdem Ozdamar, Sevim
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (02) : 203 - 211
  • [19] Current and future treatments of spinal muscular atrophy
    Smith, Martin
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2020, 62 (03): : 267 - 267
  • [20] Future vaccines - Recent advances and future prospects
    Coffin, SE
    PRIMARY CARE, 2001, 28 (04): : 869 - +